Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Other 4Thoracic 3Other solid neoplasm 3Lymphoid 3Tumor-Agnostic 2Other neoplasm 2Gynecologic 2Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Lung Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1

Interventions

Docetaxel 409pembrolizumab 331Prednisone 289enzalutamide 283Gemcitabine 274Radiotherapy 270Magnetic Resonance Spectroscopy 269Nivolumab 252Abiraterone Acetate 217Cisplatin 212Leuprolide 195Radiosurgery 192Sunitinib 188Carboplatin 161Androgen Antagonists 156bicalutamide 152Specimen Handling 149Goserelin 149Ipilimumab 131Paclitaxel 126acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 122apalutamide 117Cyclophosphamide 117Bevacizumab 116Sorafenib 114Everolimus 111abiraterone 106cabozantinib 104atezolizumab 104Biopsy 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mindfulness-Based Stress Reduction × Genitourinary × Clear all
NCT02783079 2016-05-26

Insomnia Interventions in Cancer Survivors

The Cooper Health System

Phase NA Unknown
210 enrolled
BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Colonic Neoplasms, Sleep Initiation and Maintenance Disorders, Lung Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡